EV/EBITDA
-1.21
-0.01-0.83%
3 min ago
Summary:
Century Therapeutics EV/EBITDA is currently -1.21, with a fall of -0.01 (-0.83%) during the most recent trading day. Over the past year, it has dropped by -0.53 (-77.94%). IPSC EV/EBITDA is now -98.36% below its all-time high of -0.61.IPSC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -0.8% |
| 1 m1 month | -21.0% |
| 3 m3 months | +14.2% |
| 6 m6 months | +46.5% |
| ytdytd | +26.7% |
| 1 y1 year | -77.9% |
| 5 y5 years | - |
IPSC EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.85 | -42.4% | -1.21 | at low |
| 3 m | 3 months | -0.85 | -42.4% | -1.45 | +16.6% |
| 6 m | 6 months | -0.85 | -42.4% | -2.52 | +52.0% |
| 1 y | 1 year | -0.66 | -83.3% | -2.85 | +57.5% |
| 3 y | 3 years | -0.61 | -98.4% | -12.26 | +90.1% |
| 5 y | 5 years | -0.61 | -98.4% | -24.42 | +95.0% |
| alltime | all time | -0.61 | -98.4% | -24.42 | +95.0% |
Century Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -1.21(-26.7%) |
| 2023 | -1.65(-26.7%) |
| Date | Value |
|---|---|
| 2022 | -2.25(-75.6%) |
| 2021 | -9.24 |
FAQ
- What is Century Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Century Therapeutics?
- What is IPSC EV/EBITDA year-to-date change?
- What is Century Therapeutics EV/EBITDA year-on-year change?
What is Century Therapeutics EV/EBITDA?
The current EV/EBITDA of IPSC is -1.21
What is the all time high EV/EBITDA for Century Therapeutics?
Century Therapeutics all-time high EV/EBITDA is -0.61
What is IPSC EV/EBITDA year-to-date change?
Century Therapeutics EV/EBITDA has changed by +0.44 (+26.67%) since the beginning of the year
What is Century Therapeutics EV/EBITDA year-on-year change?
Over the past year, IPSC EV/EBITDA has changed by -0.53 (-77.94%)